Video
Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.
Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.
This video was taken at ASHP's Summer Meetings and Exposition in June 2015.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.